Quest PharmaTech Inc

Type: Company
Name: Quest PharmaTech Inc
First reported Sep 17 2014 - Updated Sep 17 2014 - 1 reports

Quest PharmaTech Provides Financial Update

You currently are not registered for any FirstWord Pharma services.Register to FirstWord Pharma for free access to 10 articles every 30 days: Quest PharmaTech Provides FinancialUpdate You can also: Wait 2 days for your content allowance to be renewed. ... [Published FirstWord Pharma - Sep 17 2014]
First reported Sep 16 2014 - Updated Sep 16 2014 - 2 reports

Quest Pharmatech's $12-million investment deal dropped

Dr. Madi Madiyalakan reportsQUEST PHARMATECH PROVIDES FINANCIAL UPDATEQuest Pharmatech Inc. has provided the following financial update.Under mutually agreed terms, AD Biotech and Quest have determined to terminate the $12,000,000 investment agreement ... [Published Stockwatch - Sep 16 2014]
First reported Jun 09 2014 - Updated Jun 09 2014 - 1 reports

Quest PharmaTech Completes Patient Enrollment in Phase IIb Study of Oregovomab for the Immunotherapy of Ovarian Cancer

TSX Venture: QPTEDMONTON, June 9, 2014 /PRNewswire/ - Quest PharmaTech Inc. (TSX-V: QPT) ("Quest" or the "Company"), a pharmaceutical company developing and commercializing products for the treatment of cancer, reports today that patient enrollment has ... [Published PR Newswire: Health - Jun 09 2014]

Quotes

"Quest has been challenged financially these past few months due to AD Biotech's inability to provide the necessary funding under the investment financing agreement. In spite of that hurdle, I am pleased with the Company's response and I am optimistic about the Company's future as we seek long term financing, await clinical data and position the Company for growth in the future" said Mr. Pierre Vermette, CFO of Quest.In other news, the Company announces that it will hold its shareholder AGM on November 6, 2014
Quest chief executive officer Madi Madiyalakan said: "We look forward to working with Oncovir in the conduct of this important clinical trial combining Hiltonol with Oregovomab."

More Content

All (5) | News (3) | Reports (0) | Blogs (1) | Audio/Video (0) | Fact Sheets (0) | Press Releases (0)
sort by: Date | Relevance
Quest PharmaTech Provides Financial Update [Published FirstWord Pharma - Sep 17 2014]
Quest Pharmatech's $12-million investment deal ... [Published Stockwatch - Sep 16 2014]
QUEST PHARMATECH : Provides Financial Update [Published 4 Traders - Sep 16 2014]
Quest PharmaTech Completes Patient Enrollment i... [Published PR Newswire: Health - Jun 09 2014]
Quest and Oncovir to evaluate combinatorial imm... [Published Pharmaceutical Technology - Jan 31 2014]
1
Content Volume
Document Volume
Network
Network

Blogs

sort by: Date | Relevance
Quest PharmaTech Completes Patient Enrollment i... [Published PR Newswire: Health - Jun 09 2014]
TSX Venture: QPTEDMONTON, June 9, 2014 /PRNewswire/ - Quest PharmaTech Inc. (TSX-V: QPT) ("Quest" or the "Company"), a pharmaceutical company developing and commercializing products for the treatment of cancer, reports today that patient enrollment has ...
1
Contact Us
Sales
Support


Freebase CC-BY Some image thumbnails are sourced from Freebase, licensed under CC-BY

Copyright (C) 2014 Silobreaker Ltd. All rights reserved.
The selection and placement of stories and images on any Silobreaker page are determined automatically by a computer program.
The time or date displayed reflects when an article was added to or updated in Silobreaker.